Switch to: References

Add citations

You must login to add citations.
  1. Molecular Tumor Boards: Ethical Issues in the New Era of Data Medicine.Henri-Corto Stoeklé, Marie-France Mamzer-Bruneel, Charles-Henry Frouart, Christophe Le Tourneau, Pierre Laurent-Puig, Guillaume Vogt & Christian Hervé - 2018 - Science and Engineering Ethics 24 (1):307-322.
    The practice and development of modern medicine requires large amounts of data, particularly in the domain of cancer. The future of personalized medicine lies neither with “genomic medicine” nor with “precision medicine”, but with “data medicine”. The establishment of this DM has required far-reaching changes, to establish four essential elements connecting patients and doctors: biobanks, databases, bioinformatic platforms and genomic platforms. The “transformation” of scientific research areas, such as genetics, bioinformatics and biostatistics, into clinical specialties has generated a new vision (...)
    Download  
     
    Export citation  
     
    Bookmark   4 citations  
  • Expanding the Ethical Analysis of Biobanks.Mark A. Rothstein - 2005 - Journal of Law, Medicine and Ethics 33 (1):89-101.
    Biobanks are repositories of human biological materials collected for biomedical research. There are over 300 million stored specimens in the United States, and the number grows by 20 million per year. In the post-genome world of high throughput gene sequencing and computational biology, biobanks hold the promise of facilitating large-scale research studies. New organizational and operational models of research repositories also raise complex issues of big science, big business, and big ethical concerns.
    Download  
     
    Export citation  
     
    Bookmark   16 citations  
  • Qualitative study of knowledge and attitudes to biobanking among lay persons in Nigeria.Michael A. Igbe & Clement A. Adebamowo - 2012 - BMC Medical Ethics 13 (1):27-.
    Background Interest in biobanking for collection of specimens for non-communicable diseases research has grown in recent times. This paper explores the perspectives of Nigerians on donation of specimen for the biobanking research. Methods We conducted 16 Focus Group Discussions (FGD) with individuals from different ethnic, age and socio-economic groups in Kano (North), Enugu (Southeast), Oyo States (Southwest) and Abuja, the Federal Capital Territory (Central) of Nigeria. We used topic guides and prompt statements to explore the knowledge and understanding of interviewees (...)
    Download  
     
    Export citation  
     
    Bookmark   14 citations  
  • IRB practices and policies regarding the secondary research use of biospecimens.Aaron J. Goldenberg, Karen J. Maschke, Steven Joffe, Jeffrey R. Botkin, Erin Rothwell, Thomas H. Murray, Rebecca Anderson, Nicole Deming, Beth F. Rosenthal & Suzanne M. Rivera - 2015 - BMC Medical Ethics 16 (1):32.
    As sharing and secondary research use of biospecimens increases, IRBs and researchers face the challenge of protecting and respecting donors without comprehensive regulations addressing the human subject protection issues posed by biobanking. Variation in IRB biobanking policies about these issues has not been well documented.
    Download  
     
    Export citation  
     
    Bookmark   8 citations  
  • Informed Consent and Biobanks.Ellen Wright Clayton - 2005 - Journal of Law, Medicine and Ethics 33 (1):15-21.
    Biomedical research has always relied on access to human biological materials and clinical information, resources that when combined form biobanks. In the past, it appears that investigators sometimes used these resources with relatively little oversight, and without the consent of the individuals from whom these materials and information were obtained. Several developments in the last ten to fifteen years have converged to place greater emphasis on the role of individual consent in the creation and use of biobanks. The most important (...)
    Download  
     
    Export citation  
     
    Bookmark   16 citations  
  • DNA databanks and consent: A suggested policy option involving an authorization model. [REVIEW]Timothy Caulfield, Ross E. G. Upshur & Abdallah Daar - 2003 - BMC Medical Ethics 4 (1):1-4.
    Background Genetic databases are becoming increasingly common as a means of determining the relationship between lifestyle, environmental exposures and genetic diseases. These databases rely on large numbers of research subjects contributing their genetic material to successfully explore the genetic basis of disease. However, as all possible research questions that can be posed of the data are unknown, an unresolved ethical issue is the status of informed consent for future research uses of genetic material. Discussion In this paper, we discuss the (...)
    Download  
     
    Export citation  
     
    Bookmark   32 citations  
  • Data and tissue research without patient consent: A qualitative study of the views of research ethics committees in New Zealand.Angela Ballantyne & Andrew Moore - 2018 - AJOB Empirical Bioethics 9 (3):143-153.
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  • A biobank management model applicable to biomedical research.Christiane Auray-Blais & Johane Patenaude - 2006 - BMC Medical Ethics 7 (1):1-9.
    Background The work of Research Ethics Boards (REBs), especially when involving genetics research and biobanks, has become more challenging with the growth of biotechnology and biomedical research. Some REBs have even rejected research projects where the use of a biobank with coded samples was an integral part of the study, the greatest fear being the lack of participant protection and uncontrolled use of biological samples or related genetic data. The risks of discrimination and stigmatization are a recurrent issue. In light (...)
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  • DNA databanks and consent: A suggested policy option involving an authorization model.Daar Abdallah, E. G. Upshur Ross & Caulfield Timothy - 2003 - BMC Medical Ethics 4 (1):1.
    Background Genetic databases are becoming increasingly common as a means of determining the relationship between lifestyle, environmental exposures and genetic diseases. These databases rely on large numbers of research subjects contributing their genetic material to successfully explore the genetic basis of disease. However, as all possible research questions that can be posed of the data are unknown, an unresolved ethical issue is the status of informed consent for future research uses of genetic material. Discussion In this paper, we discuss the (...)
    Download  
     
    Export citation  
     
    Bookmark   9 citations